Company record · BIIB · Biological Products, (No Diagnostic Substances)
Biogen
The principal financial officer who signed Biogen's latest annual report is Robin C. Kramer, verified February 6, 2026.
Roster record
| Officer | Robin C. Kramer |
|---|---|
| Verified | February 6, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-04-28 also names Robin C. Kramer alongside a Chief Financial Officer title. An 8-K with Item 5.02 was filed on 2026-03-11, after this 10-K; any CFO change it reports is tracked on the moves record. |
- sec.gov · signature block · “/S/ ROBIN C. KRAMER Executive Vice President and Chief Financial Officer (principal financial officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.